Active substance
Bisacodyl
- SFDA 7
- Health Canada 16
- US price lines 2
- NHS prices 3
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DULCOLAX 5MG ENTERIC COATED TABLET | 5 mg | Coated tablet · Oral use | 40 Blister | SAR 14.55 | NCE · OTC | A. Nattermann and Cie Gmbh | Valid |
| LAXOCODYL 10MG SUPP | 10 mg | Suppository · Rectal use | 10 Blister | SAR 7.55 | NCE · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| LAXOCODYL 5 MG TABLET | 5 mg | Enteric-coated tablet · Oral use | 20 Blister | SAR 5.60 | NCE · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| LAXOCODYL 5MG SUPP | 5 mg | Suppository · Rectal use | 10 Blister | SAR 7.55 | NCE · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| DULCOLAX 5MG ENTERIC COATED TAB. | 5 mg | Gastro-resistant tablet · Oral use | 30 Blister | SAR 6.45 | NCE · OTC | DELPHARM REIMS S.A.S | Withdrawn by MAH · Not Marketed |
| DULCOLAX 5MG ENTERIC COATED TABLET | 5 mg | Coated tablet · Oral use | 30 Blister | SAR 6.45 | NCE · OTC | BOEHRINGER INGELHEIM | Withdrawn by MAH · Not Marketed |
| DULCOLAX 5MG ENTERIC COATED TABLET | 5 mg | Gastro-resistant tablet · Oral use | 30 Blister | SAR 8.40 | NCE · OTC | SANOFI AVENTIS DEUTSCHLAND GMBH | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ANAL FISSURE
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| AMB-BISACODYL | 02520478 | 10 MG | SUPPOSITORY · RECTAL | AMBICARE PHARMACEUTICALS INC. |
| BISACODYL LAXATIVE | 02499126 | 5 MG | TABLET · ORAL | LSL MEDPLUS INC |
| BISACODYL SUPPOSITORY | 02361450 | 10 MG | SUPPOSITORY · RECTAL | JAMP PHARMA CORPORATION |
| BISACODYL SUPPOSITORY | 02489090 | 10 MG | SUPPOSITORY · RECTAL | ANGITA PHARMA INC. |
| BISACODYL TABLETS | 02417413 | 5 MG | TABLET · ORAL | SIGMA LIFE SCIENCES INC. |
| BISACODYL TABLETS 5MG | 02243838 | 5 MG | TABLET · ORAL | VITA HEALTH PRODUCTS INC |
| BISACODYL TABLETS, 5 MG | 02550997 | 5 MG | TABLET · ORAL | TIME-CAP LABORATORIES, INC |
| BISACODYL-ODAN | 02273411 | 5 MG | TABLET (DELAYED-RELEASE) · ORAL | ODAN LABORATORIESLTD |
| CARTER'S LITTLE PILLS | 02219190 | 5 MG | TABLET · ORAL | CHURCH & DWIGHT CANADA CORP |
| CODULAX TABLETS | 02238155 | 5 MG | TABLET · ORAL | SIGMA LIFE SCIENCES INC. |
| DULCOLAX | 00003875 | 10 MG | SUPPOSITORY · RECTAL | OPELLA CANADA INC. |
| DULCOLAX | 00254142 | 5 MG | TABLET (ENTERIC-COATED) · ORAL | OPELLA CANADA INC. |
| DULCOLAX FOR WOMEN | 02397854 | 5 MG | TABLET (DELAYED-RELEASE) · ORAL | OPELLA CANADA INC. |
| JAMP-BISACODYL | 02246039 | 5 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| LAXATIVE FOR WOMEN | 02450232 | 5 MG | TABLET · ORAL | SIGMA LIFE SCIENCES INC. |
| THE MAGIC BULLET | 02241091 | 10 MG | SUPPOSITORY · RECTAL | SCI SUPPLY INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | BISACODYL 10 MG SUPPOSITORY | $0.3197 | per EA | 23 Sep 2026 |
| US NADAC | BISACODYL EC 5 MG TABLET | $0.04406 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Bisacodyl 10mg suppositories | £3.43 | 12 suppository | 1 Oct 2026 |
| NHS Drug Tariff | Bisacodyl 5mg gastro-resistant tablets | £2.22 | 60 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Bisacodyl 5mg suppositories | £1.11 | 5 suppository | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 17.4. Laxatives · core
Therapeutic equivalent to senna for Constipation
Combinations containing Bisacodyl
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.